메뉴 건너뛰기




Volumn 2, Issue 3, 2005, Pages 413-419

Summary of the American College for Advancement in Medicine May 2005 Conference: Menopause, andropause: Power in transition

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYACID; ANDROGEN; ANDROSTANOLONE; ANTIFUNGAL AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA GLUCAN; CAROTENOID; COPPER; ENDOCRINE DISRUPTOR; ESTROGEN; FLAVONOID; GREEN TEA EXTRACT; GROWTH HORMONE; HORMONE; HYDROCORTISONE; IDEBENONE; INTERSTITIAL COLLAGENASE; POLYPHENOL; PROCYANIDIN; PROGESTERONE; PROPIVERINE; PROTEIN TYROSINE KINASE INHIBITOR; RETINOL; SUPEROXIDE DISMUTASE; TESTOSTERONE; TOCOPHEROL; UNINDEXED DRUG; VITAMIN D; ZINC;

EID: 24344494412     PISSN: 1741427X     EISSN: None     Source Type: Journal    
DOI: 10.1093/ecam/neh113     Document Type: Conference Paper
Times cited : (7)

References (2)
  • 1
    • 0141705375 scopus 로고    scopus 로고
    • Effects of estrogen plus progestin on risk of fracture and bone mineral density: The Women's Health Initiative randomized trial
    • Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. J Am Med Assoc 2003;290:1729-38.
    • (2003) J Am Med Assoc , vol.290 , pp. 1729-1738
    • Cauley, J.A.1    Robbins, J.2    Chen, Z.3
  • 2
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
    • Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2000;288:321-33.
    • (2000) J Am Med Assoc , vol.288 , pp. 321-333
    • Rossouw, J.E.1    Anderson, G.L.2    Prentice, R.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.